Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults

Lactobacillus johnsonii N6.2 mitigates the onset of type 1 diabetes (T1D) in biobreeding diabetes-prone rats, in part, through changes in kynurenine:tryptophan (K:T) ratios. The goal of this pilot study was to determine the safety, tolerance, and general immunological response of L. johnsonii N6.2 i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Marcial, Guillermo E., Ford, Amanda L., Haller, Michael J., Gezan, Salvador A., Harrison, Natalie A., Cai, Dan, Meyer, Julie L., Perry, Daniel J., Atkinson, Mark A., Wasserfall, Clive H., Garrett, Timothy, Gonzalez, Claudio F., Brusko, Todd M., Dahl, Wendy J., Lorca, Graciela L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2017
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5466969/
https://ncbi.nlm.nih.gov/pubmed/28659913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00655
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi